SMI Falls 1.10% as Swiss Heavyweights Weigh
Published on 11/19/2026 at 18:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSwiss Blue Chips Lose Ground
- The SMI ended Thursday, November 19, at 14,721.84 points, down 1.10 percent from Wednesday's close.
- Novartis and Nestlé were among the defensive heavyweights weighing on the index, according to finanzen.at.
- European equities weakened alongside softer US markets, while investor attention focused on Anthropic's planned IPO.
The SMI ended Thursday, November 19, at 14,721.84 points, down 1.10 percent from Wednesday's close of 14,886.12. The decline left Switzerland's blue-chip index near the lower end of a session marked by renewed weakness across European equities.
finanzen.at reported the closing level and said losses in defensive heavyweights such as Novartis and Nestlé weighed on the Zurich benchmark. The source also pointed to weakness in US markets and investor attention around the upcoming Anthropic initial public offering as part of the broader market backdrop.
Heavyweights Set the Tone
The session illustrates the influence of the SMI's largest constituents. The index comprises 20 of the largest and most liquid equities in the Swiss market and covers about 75 percent of Swiss equity market capitalization, according to SIX. Moves in the major healthcare and consumer-staples names can therefore have a pronounced effect on the headline index.
Market Backdrop Remains Cautious
The European close came as investors assessed a weaker tone on Wall Street and prepared for Anthropic's stock-market debut. The finanzen.at report noted that enthusiasm surrounding the IPO had not prevented European shares from extending their losses. It also said the SMI's decline followed a further retreat in Novartis and Nestlé.
For investors, the immediate focus remains on whether selling pressure in the large defensive constituents persists and how global technology sentiment develops after the Anthropic listing. The SMI's concentration means that developments affecting a small group of heavily weighted companies can quickly influence the wider benchmark.
